克莱姆生物 CLYM
$10.29 +$1.42 (+16.01%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.34 +0.49%
开盘$9.05
昨收$8.87
当日区间$8.84 – $10.33
成交量1.14M
市值$604.42M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$15.36M-43.9% YoY
净利润-$13.50M-55.8% YoY
摊薄每股收益-$0.18-38.5% YoY
自由现金流-$10.81M+3.7% YoY
经营现金流-$10.55M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-27.1%
资产收益率-26.3%
投入资本回报率-30.4%
流动比率31.45
负债/资产比率2.7%
现金及投资$183.12M
总负债$813,000.00
净现金（净负债）$182.31M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $15.36M | $15.21M | $67.88M | $19.30M | $14.89M |
| 销售及管理费用 | $5.65M | $5.84M | $21.17M | $5.56M | $5.82M |
| -管理费用 | $5.65M | $5.84M | $21.17M | $5.56M | $5.82M |
| 研发费用 | $9.71M | $9.37M | $46.71M | $13.74M | $9.07M |
| 营业利润 | -$15.36M | -$15.21M | -$67.88M | -$19.30M | -$14.89M |
| 非经营性利息净收入（支出） | $1.86M | $1.51M | $8.32M | – | – |
| 非经营性利息收入 | $1.86M | $1.51M | $8.32M | – | – |
| 其他收入（支出） | $6,000.00 | -$25,000.00 | -$291,000.00 | -$6.54M | $2.00M |
| 证券出售收益 | $6,000.00 | -$25,000.00 | -$291,000.00 | -$46,000.00 | -$33,000.00 |
| 税前利润 | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| 净利润 | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| 持续经营利润 | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| 归属母公司净利润 | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| 归属普通股股东净利润 | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| 基本每股收益 | -$0.18 | -$0.20 | -$0.88 | -$0.26 | -$0.19 |
| 摊薄每股收益 | -$0.18 | -$0.20 | -$0.88 | -$0.26 | -$0.19 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| 其他非经营性收入（支出） | – | – | – | – | $2.04M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $246.29M | $152.37M | $167.74M | $167.74M | $182.30M |
| 流动资产合计 | $186.64M | $113.40M | $105.85M | $105.85M | $90.96M |
| 现金及现金等价物与短期投资 | $183.12M | $109.56M | $101.08M | $101.08M | $86.90M |
| -现金及现金等价物 | $44.11M | $8.36M | $35.69M | $35.69M | $25.80M |
| -短期投资 | $139.02M | $101.21M | $65.40M | $65.40M | $61.10M |
| 预付资产 | $3.51M | $3.84M | $4.77M | $4.77M | $4.06M |
| 非流动资产合计 | $59.66M | $38.97M | $61.90M | $61.90M | $91.34M |
| 固定资产净值 | $1.91M | $697,000.00 | $793,000.00 | $793,000.00 | $880,000.00 |
| -固定资产原值 | $1.91M | $697,000.00 | $793,000.00 | $793,000.00 | $880,000.00 |
| 投资及预付款 | $56.10M | $36.74M | $59.57M | $59.57M | $88.93M |
| -可供出售证券 | $56.10M | $36.74M | $59.57M | $59.57M | $88.93M |
| 其他非流动资产 | $1.65M | $1.53M | $1.53M | $1.53M | $1.53M |
| 负债合计 | $6.75M | $4.29M | $7.27M | $7.27M | $5.30M |
| 流动负债合计 | $5.93M | $4.07M | $6.98M | $6.98M | $4.95M |
| 应付款 | $1.13M | $860,000.00 | $2.27M | $2.27M | $477,000.00 |
| -应付账款 | $1.13M | $860,000.00 | $2.27M | $2.27M | $477,000.00 |
| 一年内应计费用 | $4.01M | $2.84M | $4.40M | $4.40M | $4.17M |
| 短期债务及融资租赁负债 | $501,000.00 | $263,000.00 | $256,000.00 | $256,000.00 | $228,000.00 |
| -一年内到期融资租赁负债 | $501,000.00 | $263,000.00 | $256,000.00 | $256,000.00 | $228,000.00 |
| 其他流动负债 | $295,000.00 | $113,000.00 | $59,000.00 | $59,000.00 | $77,000.00 |
| 非流动负债合计 | $813,000.00 | $216,000.00 | $285,000.00 | $285,000.00 | $352,000.00 |
| 长期债务及融资租赁负债 | $813,000.00 | $216,000.00 | $285,000.00 | $285,000.00 | $352,000.00 |
| -长期融资租赁负债 | $813,000.00 | $216,000.00 | $285,000.00 | $285,000.00 | $352,000.00 |
| 股东权益合计 | $239.55M | $148.09M | $160.48M | $160.48M | $177.00M |
| 股东权益 | $239.55M | $148.09M | $160.48M | $160.48M | $177.00M |
| 股本 | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $7,000.00 |
| -普通股 | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $7,000.00 |
| 资本公积 | $556.56M | $451.37M | $449.76M | $449.76M | $448.74M |
| 留存收益 | -$316.95M | -$303.45M | -$289.73M | -$289.73M | -$272.21M |
| 不影响留存收益的损益 | -$67,000.00 | $157,000.00 | $435,000.00 | $435,000.00 | $469,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$10.55M | -$14.38M | -$54.36M | -$15.64M | -$12.14M |
| 持续经营经营活动现金流净额 | -$10.55M | -$14.38M | -$54.36M | -$15.64M | -$12.14M |
| 持续经营净利润 | -$13.50M | -$13.72M | -$59.85M | -$17.52M | -$12.89M |
| 持续经营损益 | -$16,000.00 | $21,000.00 | $18,000.00 | -$5,000.00 | -$1,000.00 |
| 折旧、折耗与摊销 | $33,000.00 | $38,000.00 | $97,000.00 | $30,000.00 | $29,000.00 |
| 其他非现金项目 | -$1,000.00 | $58,000.00 | $201,000.00 | $57,000.00 | $56,000.00 |
| 营运资金变动 | $1.84M | -$2.07M | -$601,000.00 | $1.27M | -$2.79M |
| -预付资产变动 | $327,000.00 | $929,000.00 | -$816,000.00 | -$706,000.00 | -$1.38M |
| -应付账款及应计费用变动 | $1.14M | -$2.94M | $1.94M | $2.01M | -$1.19M |
| -其他流动资产变动 | $304,000.00 | $0.00 | -$1.51M | $0.00 | -$162,000.00 |
| -其他流动负债变动 | $67,000.00 | -$62,000.00 | -$207,000.00 | -$39,000.00 | -$59,000.00 |
| 投资活动现金流净额 | -$57.26M | -$12.96M | $2.83M | $25.54M | $15.26M |
| 持续经营投资活动现金流净额 | -$57.26M | -$12.96M | $2.83M | $25.54M | $15.26M |
| 投资购置及出售净额 | -$57.00M | -$12.96M | $3.02M | $25.54M | $15.37M |
| 筹资活动现金流 | $103.70M | $5,000.00 | -$21,000.00 | -$21,000.00 | $0.00 |
| 持续经营筹资活动现金流净额 | $103.70M | $5,000.00 | -$21,000.00 | -$21,000.00 | $0.00 |
| 股票期权行使所得 | $335,000.00 | $5,000.00 | $65,000.00 | $65,000.00 | $0.00 |
| 期末现金余额 | $44.25M | $8.36M | $35.69M | $35.69M | $25.80M |
| 现金净变动 | $35.89M | -$27.33M | -$51.54M | $9.88M | $3.12M |
| 期初现金余额 | $8.36M | $35.69M | $87.23M | $25.80M | $22.68M |
| 汇率变动影响 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 自由现金流 | -$10.81M | -$14.38M | -$54.54M | -$15.64M | -$12.25M |
| 固定资产购置及出售净额 | – | – | -$186,000.00 | $0.00 | -$109,000.00 |
| 普通股发行净额 | – | – | $0.00 | $0.00 | $0.00 |
| 其他筹资费用净额 | – | – | -$86,000.00 | – | – |
暂无评论——快来第一个聊聊 CLYM。
登录后参与讨论。